Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities
Net income	$ 1,179	$ 1,105
Adjustments to net income:
Depreciation	424	346
Amortization of capitalized software	20	16
Stock compensation	116	106
Gains on sales of assets	0	(129)
Deferred taxes	(87)	(71)
Increase (decrease) from changes in:
Accounts receivable	(141)	116
Inventories	(160)	(84)
Prepaid expenses and other current assets	(7)	(24)
Accounts payable and accrued expenses	(121)	(77)
Accrued compensation	(427)	(444)
Income taxes payable	132	212
Changes in funded status of retirement plans	(9)	17
Other	(70)	(72)
Cash flows from operating activities	849	1,017
Cash flows from investing activities
Capital expenditures	(1,123)	(1,248)
Proceeds from U.S. CHIPS and Science Act (CHIPS Act) incentives	260	0
Proceeds from asset sales	0	192
Purchases of short-term investments	(647)	(4,864)
Proceeds from short-term investments	2,807	2,631
Other	(44)	(40)
Cash flows from investing activities	1,253	(3,329)
Cash flows from financing activities
Proceeds from issuance of long-term debt	0	2,980
Repayment of debt	(750)	0
Dividends paid	(1,238)	(1,183)
Stock repurchases	(653)	(3)
Proceeds from common stock transactions	118	65
Other	(16)	(28)
Cash flows from financing activities	(2,539)	1,831
Net change in cash and cash equivalents	(437)	(481)
Cash and cash equivalents at beginning of period	3,200	2,964
Cash and cash equivalents at end of period	2,763	2,483
Supplemental cash flow information
Investment tax credit (ITC) used to reduce income taxes payable	0	0
Proceeds from CHIPS Act incentives	260	0
Total cash benefit related to the CHIPS Act	$ 260	$ 0